Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vorinostat with FCR for Untreated CLL/SLL
NCT00918723Phase 2Completed
- Sponsor
- Fred Hutchinson Cancer Center
- Start
- Jun 2009
- Primary completion
- Oct 2016
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vorinostat in chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), sponsored by Fred Hutchinson Cancer Center. Started Jun 2009; status: completed.
02
Drugs
vorinostat
03
Conditions
chronic lymphocytic leukemia (CLL)small lymphocytic lymphoma (SLL)
Beyond the preview
Go deeper on NCT00918723.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00918723.